Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
Symptoom- en syndroomdiagnosen en symptomatische therapie hoofdstuk lezen eerste hoofdstuk lezen

2018 | OriginalPaper | Hoofdstuk

46. Vergeetachtigheid (geheugenklachten)

Auteur : Drs. H. J. de Vries

Gepubliceerd in: Therapie van alledaagse klachten

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting beleid

Onderzoek is gericht op objectiveren van klachten en in kaart brengen van mogelijk beperkingen in het dagelijks functioneren. Uitsluiten van secundaire oorzaken kan grotendeels door middel van anamnese en lichamelijk onderzoek, op indicatie aangevuld met een beperkt bloedonderzoek. Verwijzing is alleen zinvol als er focale neurologische uitvalverschijnselen worden gevonden, of als er een sterke verdenking bestaat op dementie. Algemene maatregelen: begin met uitleg en geruststelling, eventueel door verwijzing naar www.​thuisarts.​nl/​vergeetachtighei​d/​ik-ben-vergeetachtig. Goede patiënteducatie is het best bewezen hulpmiddel om subjectieve geheugenklachten te verminderen. Adviezen: cognitieve geheugentraining is bewezen effectief in het verbeteren van het geheugen. Er zijn tegenwoordig tal van apps beschikbaar op de smartphone om mee te oefenen. Ook lichte fysieke inspanning werkt positief op alle vlakken van cognitie. Omdat er nauwelijks contra-indicaties zijn voor deze adviezen kunnen ze universeel gegeven worden aan patiënten met geheugenklachten. Er valt weinig effect te verwachten van het geven van voedingssupplementen. Als er geen aangetoonde deficiënties zijn, zijn deze niet aan te raden. Ook oosterse kruiden zoals ginkgo biloba en ginseng zijn niet effectief. Deze middelen hebben echter weinig bijwerkingen en hoeven niet actief afgeraden te worden. Medicamenteuze behandelingen, onder meer cholinesteraseremmers, zijn aangetoond niet zinvol. Vanwege de kans op bijwerkingen worden deze middelen afgeraden.
vorige hoofdstuk Sombere stemming
Literatuur
1.
2.
Mitchell AJ. The clinical significance of subjective memory complaints in the diagnosis of mild cognitive impairment and dementia: a meta-analysis. Int J Geriatr Psychiatry. 2008;23(11):1191–202.CrossRefPubMed
3.
4.
Abdulrab K, Heun R. Subjective Memory Impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria. Eur Psychiatry. 2008;23(5):321–30.CrossRefPubMed
5.
Wind AW, Vries H de, Pijnenburg YAL. Vergeetachtigheid. In: Jongh TOH de, Vries H de, Grundmeijer HGLM, Knottnerus BJ, redactie. Diagnostiek van alledaagse klachten. Vierde herziene druk. Houten: Bohn Stafleu van Loghum; 2016.
6.
McDade E, Ronald D, Petersen C. Mild cognitive impairment: epidemiology, pathology and clinical assessment. www.​uptodate.​com. Geraadpleegd april 2017.
7.
8.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM5®). Vijfde druk. Arlington VA: American Psychiatric Association Publishing; 2013.CrossRef
9.
Commissaris CJ, Ponds RW, Jolles J. Subjective forgetfulness in a normal Dutch population: possibilities for health education and other interventions. Patient Educ Couns. 1998;34(1):25–32.CrossRefPubMed
10.
Reid LM, MacLullich AMJ. Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord. 2006;22(5–6):471–85.CrossRefPubMed
11.
Jonker C, Launer LJ, Hooijer C, Lindeboom J. Memory complaints and memory impairment in older individuals. J Am Geriatr Soc. 1996;44(1):44–9.CrossRefPubMed
12.
Larrabee GJ, Crook TH. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatrics. 1994;6(1):95–104.CrossRef
13.
Prince M, Bryce R, Albanese E, et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75.e2.
14.
Wang L, Belle G van, Crane PK, et al. Subjective memory deterioration and future dementia in people aged 65 and older. J Am Geriatr Soc. 2004;52(12):2045–51.CrossRefPubMed
15.
Mol MEM, Boxtel MPJ van, Willems D, Jolles J. Do subjective memory complaints predict cognitive dysfunction over time? A six-year follow-up of the Maastricht Aging Study. Int J Geriatr Psychiatry. 2006;21(5):432–41.CrossRefPubMed
16.
Brodaty H, Pond D, Kemp NM, et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc. 2002;50(3):530–4.CrossRefPubMed
17.
Kwok TCY, Bai X, Li JCY, et al. Effectiveness of cognitive training in Chinese older people with subjective cognitive complaints: a randomized placebo-controlled trial. Int J Geriatr Psychiatry. 2013;28(2):208–15.CrossRefPubMed
18.
Metternich B, Kosch D, Kriston L, et al. The effects of nonpharmacological interventions on subjective memory complaints: a systematic review and meta-analysis. Psychother Psychosom. 2010;79(1):6–19.CrossRefPubMed
19.
Pereira-Morales AJ, Cruz-Salinas AF, Aponte J, Pereira-Manrique F. Efficacy of a computer-based cognitive training program in older people with subjective memory complaints: a randomized study. Int J Neurosci. 2017 Jul 19:1−9. doi: 10.​1080/​00207454.​2017.
20.
Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev. 2011;CD006220.
21.
Oh SJ, Seo S, Lee JH, et al. Effects of smartphone-based memory training for older adults with subjective memory complaints: a randomized controlled trial. Aging Ment Health. 2017;10:1–9.CrossRef
22.
Martin M, Clare L, Altgassen AM, et al. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev. 2011;CD006220.
23.
Kamegaya T, Maki Y, Yamagami T, et al. Pleasant physical exercise program for prevention of cognitive decline in community-dwelling elderly with subjective memory complaints. Geriatr Gerontol Int. 2012;12(4):673–9.CrossRefPubMed
24.
Young J, Angevaren M, Rusted J, Tabet N. Aerobic exercise to improve cognitive function in older people without known cognitive impairment. In: Young J, redactie. Cochrane Database Syst Rev. 2015;CD005381.
25.
Russ T, Morling J. Cholinesterase inhibitors for mild cognitive impairment. Cochrane Database Syst Rev. 2012;CD009132.
26.
27.
Raschetti R, Albanese E, Vanacore N, Maggini M. Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Med. 2007 Nov 27;4(11):e338.CrossRefPubMedPubMedCentral
28.
Salloway S, Correia S, Richardson S. Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI. Int Psychogeriatrics. 2008 Feb 28;20(1):40–6.CrossRef
29.
Asih PR, Wahjoepramono EJ, Aniwiyanti V, et al. Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety. CNS Neurol Disord Drug Targets. 2015;14(5):576–86.CrossRefPubMed
30.
Wahjoepramono EJ, Asih PR, Aniwiyanti V, et al. The effects of testosterone supplementation on cognitive functioning in older men. CNS Neurol Disord Drug Targets. 2016;15(3):337–43.CrossRefPubMedPubMedCentral
31.
Resnick SM, Matsumoto AM, Stephens-Shields AJ, et al. Testosterone treatment and cognitive function in older men with low testosterone and age-associated memory impairment. JAMA. 2017 Feb 21;317(7):717–27.CrossRefPubMedPubMedCentral
32.
Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev. 2008;CD004514.
33.
Vakhapova V, Cohen T, Richter Y, et al. Phosphatidylserine containing ω–3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010;29(5):467–74.CrossRefPubMed
34.
Jorissen BL, Brouns F, Boxtel MP van, et al. The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment. Nutr Neurosci. 2001;4(2):121–34.CrossRefPubMed
35.
Kato-Kataoka A, Sakai M, Ebina R, et al. Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. J Clin Biochem Nutr. 2010;47(3):246–55.CrossRefPubMedPubMedCentral
36.
Crook TH, Tinklenberg J, Yesavage J, et al. Effects of phosphatidylserine in age-associated memory impairment. Neurology. 1991;41(5):644–9.CrossRefPubMed
37.
Cenacchi T, Bertoldin T, Farina C, et al. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging (Milano). 1993;5(2):123–33.PubMed
38.
Richter Y, Herzog Y, Lifshitz Y, et al. The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a pilot study. Clin Interv Aging. 2013;8:557–63.PubMedPubMedCentral
39.
Scholey A, Camfield D, Hughes M, Woods WKSC. A randomized controlled trial investigating the neurocognitive effects of Lacprodan® PL-20, a phospholipid-rich milk protein concentrate, in elderly participants with age-associated memory impairment: the phospholipid intervention for cognitive ageing reversal (PLICAR): study protocol for a randomized controlled trial. Trials. 2013;14(1):404.CrossRefPubMedPubMedCentral
40.
Carlson JJ, Farquhar JW, DiNucci E, et al. Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J Am Diet Assoc. 2007;107(3):422–32.CrossRefPubMed
41.
Solomon PR, Adams F, Silver A, et al. Ginkgo for memory enhancement: a randomized controlled trial. JAMA. 2002;288(7):835–40.CrossRefPubMed
42.
Beck SM, Ruge H, Schindler C, et al. Effects of ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment – a randomized double-blind placebo-controlled trial. Hum Psychopharmacol. 2016;31(3):227–42.CrossRefPubMedPubMedCentral
43.
Snitz BE, O’Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults; a randomized trial. JAMA. 2009;302(24):2663.CrossRefPubMedPubMedCentral
44.
O’Brien JT, Burns A. BAP Dementia Consensus Group. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. 2011;25(8):997–1019.CrossRefPubMed
45.
Geng J, Dong J, Ni H, et al. Ginseng for cognition. Cochrane Database Syst Rev. 2010;CD007769.
Metagegevens
Titel
Vergeetachtigheid (geheugenklachten)
Auteur
Drs. H. J. de Vries
Copyright
2018
Uitgeverij
Bohn Stafleu van Loghum
Boek
Therapie van alledaagse klachten

Print ISBN: 978-90-368-1921-3

Elektronisch ISBN: 978-90-368-1922-0

Copyright: 2018

DOI
https://doi.org/10.1007/978-90-368-1922-0_46